<DOC>
	<DOCNO>NCT03106701</DOCNO>
	<brief_summary>This study represent extension previous study ( NCT02641431 ) acute long-term benefit epicardial ablation elimination BrS-ECG pattern VT/VF inducibility 200 consecutive BrS patient .</brief_summary>
	<brief_title>Epicardial Ablation Brugada Syndrome . An Extension Study 200 BrS.Patients</brief_title>
	<detailed_description>According previous protocol ( NCT02641431 ) , additional consecutive select patient ICD implantation enrol total 200 BrS patient . Three-dimensional color-coded voltage , activation duration electroanatomical map ajmaline ( 1mg/kg 5 minute ) wiil determine site size arrhythmogenic substrate characterize abnormally prolong fragment ventricular potential . Primary endpoint identification elimination electrophysiological substrate RF application lead ECG pattern normalization VT/VF non-inducibility ajmaline . Patients follow 48 month ablation sequential 12-lead ECG Holter recording , ICD interrogation , VT/VF inducibility ajmaline test .</detailed_description>
	<mesh_term>Brugada Syndrome</mesh_term>
	<criteria>Symptomatic BrS patient , ICD implantation , spontaneous ajmalineinduced type 1 Br pattern . Age &lt; 18 year , prior epicardial ablation , pregnancy , comorbidities .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>